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Phosphorylation by protein kinases is recognized as a major
mechanism by which virtually every activity of eukaryotic
cells is regulated, including proliferation, gene expression,
metabolism, motility, membrane transport, and apoptosis.
An ultimate goal of research into signal transduction is to
reach a full understanding of the protein phosphorylation
events that occur within individual cell types and how they
eventually impact on cell behavior. A milestone en route to
this ambitious goal is a determination of the number of
protein kinases encoded by eukaryotic genomes and an
assessment of their structures, functions, and evolutionary
relationships. This article traces the progress made toward
achieving these objectives in the pregenomic and genomic
eras, which culminated recently with reports on the ‘full
complement’ of human protein kinases. 
The pregenomic era 
About sixteen years ago, while working at the Salk Institute,
my colleagues and I undertook a comparative analysis of all
the available sequences of protein kinase catalytic domains
[1]. This interest stemmed from my having identified several
novel human protein kinases using a homology-based cDNA
cloning strategy [2] and wanting to determine their relation-
ships to other known protein kinases. In collaboration with
the Salk’s resident protein kinase guru Tony Hunter and bio-
computing specialist Anne Marie Quinn, we aligned the
homologous catalytic-domain amino-acid sequences of 65
distinct protein kinases from diverse eukaryotes (including
45 nonorthologous vertebrate enzymes) and constructed a
phylogenetic tree to visualize their overall relationships [1].
The alignment (produced manually at the word-processor)
defined the boundaries of the eukaryotic protein kinase
(ePK) catalytic domain, revealed conserved subdomains that
were never interrupted by amino-acid insertions, and identi-
fied highly conserved individual amino acids and motifs
(Figure 1). 
The phylogenetic tree revealed major clusters including the
tyrosine kinases (the TK group), cyclic nucleotide- and
calcium-phospholipid-dependent kinases (the AGC group;
including the PKA, PKG, and PKC families) and calmodulin-
dependent kinases (the CAMK group). These groupings indi-
cated that ePK domain phylogeny reflects substrate
specificity and/or mode of regulation and could therefore
serve as a useful classification tool. Over the next 7 years I
continued to add new sequences to the alignment as they
became available and to construct phylogenetic trees as a
means of classifying the burgeoning ePK superfamily. By
early 1994, the ePK domain alignment had grown to contain
390 sequences including 205 non-orthologous vertebrate
ePKs, and a fourth major ePK group (CMGC, comprising the
CDK, MAPK, GSK, and CLK families) had been added
through phylogenetic analysis [3]. The 390 ePK domain
alignment was made publicly available through the Protein
Kinase Resource website [4]. 
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By 1995, with the advent of genome-sequencing projects, the
task of cataloging and classifying the members of the ePK
superfamily had grown to become too distracting from my
funded research and I discontinued my efforts in this area.
Tony Hunter continued to work with bioinformaticians at
SUGEN, Inc. (including Greg Plowman, Gerard Manning,
and Sucha Sudarsanam) to characterize the full ePK comple-
ments of model eukaryotes from genomic sequence data
[5,6]. By the time of a recent report [7], their efforts had
resulted in the identification and classification of 115 distinct
ePKs from budding yeast (around 2% of all genes), 434 from
Caenorhabditis elegans (about 2.5% of all genes), and 223
from  Drosophila. In addition they described the comple-
ment of ‘atypical protein kinases’ (aPKs) from these species:
15 from yeast, 20 from C. elegans, and 16 from Drosophila.
(The aPKs are a variety of protein kinases that lack strong
sequence similarity to the classical ePK domain but have
been shown experimentally to have protein kinase activity;
well-known examples are the ‘lipid kinases’ of the phos-
phatidylinositol 3-kinase (PI3K) family, some of which have
been shown experimentally to have protein kinase activity.) 
As a result of their comprehensive analyses of ‘kinomes’, the
SUGEN investigators were able to define three new major
groups within the broad ePK classification scheme: first, the
STE group, which includes ePKs that function in the MAPK
kinase cascades that were first described through characteri-
zation of yeast sterile mutants; second, the CK1 group,
including the casein kinase 1 family and related enzymes,
which is greatly expanded in the worm; and third, the TKL
(‘tyrosine-kinase like’) group that includes the STKR family
of TGFbeta serine/threonine kinase receptors and is phylo-
genetically close to the tyrosine kinases (TKs). Many distinct
kinase families within the AGC, CAMK, CMGC, STE, and
CK1 groups have representatives from all three species, sup-
porting the idea of an early evolutionary origin and critical
function in basic cellular processes. Members of the TK and
TKL groups are notably absent from yeast, consistent with
the known functions of these ePKs in intercellular signaling
events associated with metazoan complexity. More discussion
of the evolutionary relationships among the ePKs identified
through the SUGEN genome-mining efforts has been pub-
lished elsewhere [7]. The SUGEN kinase.com website [8]
includes links to all their published work on protein kinase
analysis as well as ‘KinBase’, a very useful searchable database
that holds information on all the protein kinase genes found
in the yeast, worm, fly, and human (see below) genomes.
Human protein kinases
The completion of the first draft of the human genome
sequence presented an opportunity to determine the full
complement of human protein kinases. The first analysis
came from a group led by Mitch Kostich at Schering-Plough
Research Institute (SPRI) [9]. This group mined public
GenBank records (available before December, 2001) for ePK
sequences by performing BLAST searches using known ePK
domains as queries. The resulting hits were consolidated, and
efforts were made to remove non-human sequences, pseudo-
genes, and poor-quality sequences that could represent dupli-
cate hits. The SPRI investigators chose to err on the side of
inclusion rather than exclusion, however, and many cases of
‘single hit’ sequences were retained. Their effort culminated
in a collection of 510 potentially unique human ePKs. A color-
coded alignment that accompanied their article [9] nicely
illustrates the ePK domain sequence conservation.
The SUGEN group, led by Gerard Manning and Sucha
Sudarsanam, carried out a more comprehensive effort to
describe and classify all human ePKs [10]. They employed a
dataset that included, in addition to the public databases,
genomic reads from Celera that are not publicly available,
non-public expressed sequence tags (ESTs) from Incyte and
SUGEN, and they searched using a hidden Markov model of
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Figure 1
The ePK catalytic domain. The 12 conserved subdomains are indicated by Roman numerals. The positions of amino-acid residues and motifs highly
conserved throughout the ePK superfamily are indicated above the subdomains, using the single-letter amino-acid code with x as any amino acid. Crystal
structures show that ePK domains adopt a common fold consisting of amino-terminal and carboxy-terminal lobes connected by a hinge region. Binding of
Mg-ATP is largely the function of the amino-terminal lobe and hinge region, while peptide-substrate binding is mediated by the carboxy-terminal lobe.
Particularly important for catalytic function are the invariant lysine in subdomain II and the invariant aspartate in subdomain VII that function to anchor
and orient ATP, and the invariant aspartate in subdomain VIB which is the likely catalytic base in the phosphotransfer reaction. More detailed discussions
of ePK subdomains and conserved residues in relation to crystal structures and catalytic function can be found in [3,4,12,13].
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(peptide binding and phosphotransfer)the ePK domain that allowed detection of very divergent
family members. The sequence data were further searched
for members of the various known aPK families. Using strin-
gent criteria to eliminate false positives (including verifica-
tion of novel sequences by cDNA cloning) they compiled a
list of 478 human members of the ePK superfamily and
another 40 aPKs, bringing their human kinome total to 518
(approximately 1.7% of all predicted human genes). They
also identified 106 ePK or aPK pseudogenes. 
A comparison of the SPRI-510 and SUGEN-518 lists reveals
474 protein kinases in common (see the additional file avail-
able with this article online). Of the 44 SUGEN-specific
kinases, 32 are aPKs; the other 8 aPKs identified by SUGEN,
from the ABC1 and RIO families, were included in the SPRI
list as a result of their having weak ePK domain similarity.
Of the remaining 12 SUGEN-specific ePKs, five (TAK1,
MLKL, NEK5, SgK307, and TBCK) were not available in the
public data used in the SPRI analysis; another five (SgK196,
SgK223, SgK424, SgK493, and Slob) have rather divergent
ePK domains that lack many of the highly conserved residues
and are unlikely to have catalytic activity, so it is easy to see
how these might have been excluded by visual inspection;
and the final two are SgK110 and NEK10. SgK110 was actually
detected by the SPRI search, but it was erroneously merged
with a related sequence AC008735_EPK1 (SgK069) on the
same genomic contig; and it is unclear why the SPRI group
missed NEK10. Most, if not all, of the 36 SPRI-specific ePKs
represent over-inclusion errors (Table 1): 14 correspond to
sequences determined to be pseudogenes by the SUGEN
group; 19 are based on single sequences that are (or appear to
be) either poor-quality duplicates of other ePKs or inter-
species contaminants; and the remaining three are duplicates
arising by virtue of non-overlapping partial sequences.
Thus the SUGEN compilation of 478 human ePK superfamily
genes represents the accurate count based on current
sequence data. If one subtracts those that lack key conserved
residues, we are left with 428 human ePKs with known or
likely kinase function (Table 2), 99% of which were included
in the SPRI list; 365 of these fall within the seven major ePK
groups: TK, 84 in total; CAMK, 66; AGC, 61; CMGC, 61; STE,
45; TKL, 37; and CK1, 11. The remaining 63 are in the ‘Other’
category, falling outside the main ePK group branches. Krupa
and Srinivasan [11] have also recently searched the public
human genome data with a focus on identifying functional
protein kinases; their efforts resulted in a list of 448 distinct
human ePK sequences, but around 90 of these appear to rep-
resent duplicate entries, and no novel protein kinases were
identified that were not present in the SUGEN compilation. 
Usefulness of the kinome data
Knowing the full complement of ePK family members and
functional ePKs encoded by eukaryotic genomes will have
great impact upon many areas of scientific investigation. As
mentioned above, an obvious benefit relates to understanding
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Table 1
Putative ePKs identified by SPRI but not SUGEN 
Category SPRI name Comment
14 pseudogenes LOC95530 Corresponds to SUGEN MAP2K2ps
AC008014_EPK1 Corresponds to SUGEN MARKps22
AC023095_EPK1 Corresponds to SUGEN PLK1ps1
AC024933_EPK1 Corresponds to SUGEN MARKps30
AC091554_EPK1 Corresponds to SUGEN SRPK2ps
AI621045 Corresponds to SUGEN SgK384ps
AI991174 Corresponds to SUGEN TSSKps2
AL138964_EPK1 Corresponds to SUGEN MARKps23
AL161450_EPK1 Corresponds to SUGEN CK1g2ps
AL390061_EPK1 Corresponds to SUGEN MNK1ps
BG742738 Corresponds to SUGEN TLK2ps2
LOC65348 Corresponds to SUGEN CDK7ps
LOC65743 Corresponds to SUGEN PAK2ps
LOC85643 Corresponds to SUGEN CLK2ps
11 duplicates  AI342911 Corresponds to SUGEN CLK3
from poor-
AA565761 Corresponds to SUGEN CLK3 quality
AI826899 Corresponds to SUGEN CDK4 single-EST
AW148845 Corresponds to SUGEN ILK
sequences
AW674733 Corresponds to SUGEN ILK
AA730234 Corresponds to SUGEN MAP2K7
AI075923 Corresponds to SUGEN TSSK4
AI206530 Corresponds to SUGEN TLK1
AW518044 Corresponds to SUGEN MPSK1
AL538014 Corresponds to SUGEN BRSK2
BG986727 Corresponds to SUGEN Obscn
Four non- AC025598 Mus musculus MAP2K6
human 
AC026940_EPK1 Mus musculus CDK7 sequences
PKCETB Rattus norvegicus PKCeta
CAMKII Sus scrofa sequence, subsequently
recalled
Three duplicates  AC023837_EPK1 Part of EphA6
from non-
AA263006 Part  of HIPK1 (along with BE180036) overlapping 
BE567816 Part of YANK1 (along with BG036777) partial sequences
Four others AW499744 Single EST; does not seem to encode
an ePK
AJ336398_EPK1 Single genomic sequence, possibly
prokaryotic
AL512402_EPK1 Single genomic sequence, possibly 
nonhuman
ILK2 Possibly murine ILK; published as 
human [16]111.4 Genome Biology 2003, Volume 4, Issue 5, Article 111 Hanks http://genomebiology.com/2003/4/5/111
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Table 2
The 428 human ePKs with known or likely kinase catalytic function
Group Number Family Number Family members
within group within family (SUGEN nomenclature)
TK 84 Ack 2 ACK, TNK1
Abl 2 ABL, ARG
Csk 2 CSK, CTK
FAK 2 FAK, PYK2
Fer 2 FER, FES
JAK 4 JAK1, JAK2, JAK3, TYK2
Src 11 BLK, BRK, FGR, FRK, FYN, HCK, LCK, LYN, SRC, SRM, YES
Syk 2 SYK, ZAP70
Tec 5 BMX, BTK, ITK, TEC, TXK
Alk 2 ALK, LTK
Axl 3 AXL, MER, TYRO3
DDR 2 DDR1, DDR2
EGFR 3 EGFR, HER2/ErbB2, HER4/ErbB4
Eph 12 EphA1, EphA2, EphA3, EphA4, EphA5, EphA6, EphA7, EphA8, EphB1, EphB2, EphB3, EphB4
FGFR 4 FGFR1, FGFR2, FGFR3, FGFR4
InsR 3 IGF1R, INSR, IRR
Lmr 3 LMR1, LMR2, LMR3
Met 2 MET, RON
Musk 1 MUSK
PDGFR/VEGFR 8 FLT3, FMS, KIT, PDGFRa, PDGFRb, FLT1, FLT4, KDR
Ret 1 RET
Ror 2 ROR1, ROR2
Sev 1 ROS
Tie 2 TIE1, TIE2
Trk 3 TRKA, TRKB, TRKC
AGC 61 PKA 5 PKACa, PKACb, PKACg, PRKX, PRKY
PKG 2 PKG1, PKG2
PKC 9 PKCa, PKCb, PKCd, PKCe, PKCg, PKCh, PKCi, PKCt, PKCz
AKT 3 AKT1, AKT2, AKT3
DMPK 7 CRIK, DMPK1, DMPK2, MRCKa, MRCKb, ROCK1, ROCK2
GRK 7 BARK1, BARK2, GPRK4, GPRK5, GPRK6, GPRK7, RHOK
MAST 5 MAST1, MAST2, MAST3, MAST4, MASTL
NDR 4 LATS1, LATS2, NDR1, NDR2
PKB 1 PDK1
PKN 3 PKN1, PKN2, PKN3
RSK 9 MSK1, MSK2, RSK1, RSK2, RSK3, RSK4, SgK494, p70S6K, p70S6Kb
SGK 3 SGK, SGK2, SGK3
YANK 3 YANK1, YANK2, YANK3
CAMK 66 CAMK1 5 CaMK1a, CaMK1b, CaMK1d, CaMK1g, CaMK4
CAMK2 4 CaMK2a, CaMK2b, CaMK2d, CaMK2g
CAMKL 20 AMPKa1, AMPKa2, BRSK1, BRSK2, CHK1, HUNK, LKB1, MARK1, MARK2, MARK3, 
MARK4, MEL, NIM1, NuaK1, NuaK2, PASK, QIK, QSK, SIK, SNRK
DAPK  5 DAPK1, DAPK2, DAPK3, DRAK1, DRAK2
DCAMKL  3 DCAMKL1, DCAMKL2, DCAMKL3
MAPKAPK  5 MAPKAPK2, MAPKAPK3, MAPKAPK5, MNK1, MNK2
MLCK  4 caMLCK, skMLCK, smMLCK, SgK085
PHK 2 PHKg1,  PHKg2
PIM 3 PIM1, PIM2, PIM3
PKD  3 PKD1, PKD2, PKD3
PSK 1 PSKH1
RAD53 1 CHK2
Trio 4 Obscn, SPEG, Trad, Trioc
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Table 2 (continued)
Number Number
Group within group Family within family Family members
TSSK  5 SSTK, TSSK1, TSSK2, TSSK3, TSSK
CAMK-Unique 1 STK33
CMGC 61 CDK 20 CCRK, CDC2, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, CDK10, 
CDK11, CHED, CRK7, PCTAIRE1, PCTAIRE2, PCTAIRE3, PFTAIRE1, PFTAIRE2, PITSLRE
MAPK 14 Erk1, Erk2, Erk3, Erk4, Erk5, Erk7, JNK1, JNK2, JNK3, NLK, p38a, p38b, p38d, p38g
GSK 2 GSK3A,  GSK3B
CLK 4 CLK1, CLK2, CLK3, CLK4
CDKL  5 CDKL1, CDKL2, CDKL3, CDKL4, CDKL5
DYRK  10 DYRK1A, DYRK1B, DYRK2, DYRK3, DYRK4, HIPK1, HIPK2, HIPK3, HIPK4, PRP4
RCK  3 ICK, MAK, MOK
SRPK  3 MSSK1, SRPK1, SRPK2
STE  45 STE7 7 MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7
STE20 28 GCK, HPK1, KHS1, KHS2, LOK, MST1, MST2, MST3, MST4, MYO3A, MYO3B, OSR1, 
PAK1, PAK2, PAK3, PAK4, PAK5, PAK6, SLK, STLK3, TAO1, TAO2, TAO3, YSK1, 
ZC1/HGK, ZC2/TNIK, ZC3/MINK, ZC4/NRK
STE11 8 MAP3K1, MAP3K2, MAP3K3, MAP3K4, MAP3K5, MAP3K6, MAP3K7, MAP3K8
STE-Unique 2 COT,  NIK
TKL 37 IRAK 2 IRAK1, IRAK4
LISK  4 LIMK1, LIMK2, TESK1, TESK2
LRRK 2 LRRK1,  LRRK2
MLK 9 DLK, HH498, LZK, MLK1, MLK2, MLK3, MLK4, TAK1, ZAK
RAF  3 ARAF, BRAF, RAF1
RIPK  5 ANKRD3, RIPK1, RIPK2, RIPK3, SgK288
STKR 12 ACTR2, ACTR2B, ALK1, ALK2, ALK4, ALK7, BMPR1A, BMPR1B, BMPR2, MISR2, 
TGFbR1, TGFbR2
CK1 11 CK1 7 CK1a, CK1a2, CK1d, CK1e, CK1g1, CK1g2, CK1g3
TTBK 2 TTBK1,  TTBK2
VRK 2 VRK1,  VRK2
Other 63 Aur 3 AurA, AurB, AurC
BUB 1 BUB1
Bud32 1 PRPK
CAMKK 2 CaMKK1,  CaMKK2
CDC7 1 CDC7
CK2 2 CK2a1,  CK2a2
IKK  4 IKKa, IKKb, IKKe, TBK1
IRE 2 IRE1,  IRE2
MOS 1 MOS
NAK  4 AAK1, BIKE, GAK, MPSK1
NEK 11 NEK1, NEK2, NEK3, NEK4, NEK5, NEK6, NEK7, NEK8, NEK9, NEK10, NEK11
NKF1  3 SBK, SgK069, SgK110
NKF2 1 PINK1
NKF4 2 CLIK1, CLIK1L
PEK 4 GCN2, HRI, PEK, PKR
PLK 4 PLK1, PLK2, PLK3, PLK4
TLK 2 TLK1, TLK2
TOPK 1 PBK
TTK 1 TTK
ULK 4 Fused, ULK1, ULK2, ULK3
VPS15 1 PIK3R4
WEE 3 MYT1, Wee1, Wee1B
Wnk 4 Wnk1, Wnk2, Wnk3, Wnk4
Other-Unique 2 KIS, SgK496of how signal transduction pathways evolved during the
course of eukaryotic evolution. Both SUGEN [10] and Krupa
and Srinivasan [11] extended their analyses to describe
other domains present in the various human ePKs which
are likely to function in directing the enzymes to relevant
substrates or modulating kinase activities. Further analysis
of the ePK domain sequences uniquely conserved within the
major groups and families, together with comparisons of
ePK domain crystal structures, should ultimately allow a
full understanding of how different classes of peptide sub-
strate are recognized. For example, Figure 2 shows consen-
sus sequences for the catalytic loop region in subdomain
VIB (which includes the invariant aspartate thought to
function as the catalytic base) and the activation loop region
in subdomain VIII (which includes the highly conserved
glutamine in the ‘APE’ motif) - two regions that have been
recognized as being primarily involved in peptide-substrate
recognition [12,13]. A number of group-specific differences
are apparent (highlighted in Figure 2) that correlate with
unique peptide-recognition tendencies for the ePKs that fall
within a given group [14]. Beyond sequence analysis, the
kinome data will allow for the development of comprehen-
sive tools (such as full-length cDNAs, microarrays, antibod-
ies, and fusion protein and RNAi constructs) that will
greatly aid laboratory investigations aimed at understand-
ing cell signaling through analysis of kinase function. As an
example of such proteomic approaches to the study of
protein kinases, nearly all yeast protein kinases have been
expressed in bacteria and analyzed for their ability to phos-
phorylate an array of protein or peptide substrates using
protein-chip technology [15]. Finally, the human kinome
data will have benefits in the understanding and treatment
of human diseases. The ePK genes that map within disease
loci are attractive etiological candidates, and knowledge of
the full repertoire of human protein kinases will greatly aid
in the development of drugs that target specific protein
kinases or protein kinase families whose function con-
tributes to disease-associated cellular defects.
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